Clearside Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-32.49	-32.95	0.38	-18.21	-30.77	-82.82	-58.98	-25.88	-17.64	-10.19
Depreciation & Amortization	0.07	0.15	0.18	0.18	0.21	0.19	0.18	0.07	0.06	0.03
Share-Based Compensation	4.2	4.88	5.05	3.6	4.61	4.79	3.36	1.31	0.71	0.43
Other Operating Activities	10.08	14.55	-16.34	1.31	-1.12	-1.36	4.35	1.79	2.97	0.61
Operating Cash Flow	-18.14	-13.37	-10.73	-13.12	-27.07	-79.2	-51.08	-22.71	-13.9	-9.12
Capital Expenditures	-1.78	-0.25	0	-0.06	-0.03	-0.09	-0.31	-0	-0.03	-0.14
Change in Investments	0	0	0	0	32.95	-3.67	20.43	-48.78	0	0
Other Investing Activities	-	-	-	-	-	-	-	-0.36	-	-
Investing Cash Flow	-1.78	-0.25	0	-0.06	32.93	-3.76	20.12	-49.14	-0.03	-0.14
Share Issuance / Repurchase	1.76	0.7	23.78	12.22	13.7	80.08	5.36	84.86	0.01	0.01
Debt Issued / Paid	-1.35	30.64	0	-4.35	-5	1.7	0	1.53	5.98	2.88
Other Financing Activities	-	-	-	-	-	-	-	-	19.95	12.74
Financing Cash Flow	0.41	31.33	23.78	7.87	8.7	81.78	5.36	86.39	25.94	15.62
Net Cash Flow	-19.5	17.72	13.05	-5.31	14.55	-1.18	-25.6	14.54	12.01	6.36
Free Cash Flow	-19.91	-13.61	-10.73	-13.18	-27.09	-79.29	-51.39	-22.71	-13.93	-9.26
Free Cash Flow Margin	-242.06%	-1025.70%	-36.29%	-166.90%	-1246.80%	-264293.33%	-14895.36%	-4367.69%	-	-
Free Cash Flow Per Share	-0.32	-0.23	-0.18	-0.28	-0.71	-2.58	-2.03	-1.73	-5.96	-5.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).